生命科学资讯

Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024

Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate

5 Insightful Analyst Questions From Thermo Fisher's Q4 Earnings Call - Finviz

PharosAI partners with 10x Genomics on spatial cancer data backed by £18.9 million - European Biotechnology Magazine

Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings

UK consortium to use 10x Genomics platform for AI-driven cancer research - Investing.com Nigeria

FDA’s rare pediatric disease voucher program revived by 2026 government funding bill

UK consortium to use 10x Genomics platform for AI-driven cancer research - Investing.com Canada

FTC settles insulin lawsuit with Express Scripts

AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates

Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout

Is Thermo Fisher Scientific (TMO) Pricing Look Reasonable After Recent Share Price Weakness - simplywall.st

Rare pediatric PRV program reauthorized until 2029 via government funding law

Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions

Financings for Feb. 4, 2026

In the clinic for Feb. 4, 2026

Other news to note for Feb. 4, 2026

Regulatory actions for Feb. 4, 2026

BARDA offers $100M in prize money for antiviral development